Skip to content
Clinical Trials – home

Cetrorelix: A Comprehensive Guide for Patients

2 / 2
trials open to patients / all trials
2+
Countries

In short

Cetrorelix is a medication that has been studied in various clinical trials for its potential benefits in reproductive health and benign prostatic hyperplasia (BPH). This article explores the use of Cetrorelix in different medical conditions, including infertility treatments, ovarian hyperstimulation syndrome (OHSS), and BPH. We'll discuss its effectiveness, safety, and potential applications based on recent clinical trials.

What is Cetrorelix?

Cetrorelix is a medication that belongs to a class of drugs known as gonadotropin-releasing hormone (GnRH) antagonists. It is also known by other names such as Cetrotide, D-20762, and AEZS-102. This drug is primarily used in reproductive medicine and for treating certain hormonal conditions.

How Cetrorelix Works

Cetrorelix works by blocking the action of a hormone called GnRH in the body. GnRH is responsible for stimulating the production of other hormones like luteinizing hormone (LH) and follicle-stimulating hormone (FSH). By blocking GnRH, Cetrorelix can help control the levels of these hormones in the body, which is useful in various medical treatments.

Medical Conditions Treated with Cetrorelix

Cetrorelix is used to treat several medical conditions:

  • Infertility and Assisted Reproductive Technology (ART): Cetrorelix is commonly used during in vitro fertilization (IVF) procedures. It helps prevent premature ovulation, allowing doctors to better control the timing of egg retrieval.
  • Benign Prostatic Hyperplasia (BPH): This is a condition where the prostate gland enlarges, causing urinary symptoms in older men. Cetrorelix has been studied for its potential to improve symptoms of BPH.
  • Endometriosis: Cetrorelix has been investigated for treating symptoms of endometriosis, a condition where tissue similar to the lining of the uterus grows outside the uterus.
  • Ovarian Hyperstimulation Syndrome (OHSS): This is a potential complication of fertility treatments. Cetrorelix has been studied for its role in preventing and treating OHSS.

Administration and Dosage

Cetrorelix is typically administered in the following ways:

  • Subcutaneous injection: This means the medication is injected just under the skin. The common dose is 0.25 mg per day.
  • Intramuscular injection: In some cases, particularly for BPH treatment, Cetrorelix may be injected into the muscle, often in the buttocks.

The exact dosage and duration of treatment depend on the specific condition being treated and the individual patient's response. Always follow your doctor's instructions regarding dosage and administration.

Clinical Trials and Research

Cetrorelix has been the subject of numerous clinical trials investigating its effectiveness for various conditions:

  • Studies have compared different protocols for using Cetrorelix in IVF treatments, such as fixed versus flexible timing of administration.
  • Research has explored the use of Cetrorelix in treating BPH, with some studies showing promising results in improving urinary symptoms.
  • Trials have investigated the potential of Cetrorelix in managing endometriosis symptoms.
  • Some studies have looked at using Cetrorelix to prevent or treat ovarian hyperstimulation syndrome in women undergoing fertility treatments.

Potential Side Effects

Like all medications, Cetrorelix can cause side effects, although not everyone experiences them. Common side effects may include:

  • Injection site reactions (redness, swelling, or itching)
  • Nausea
  • Headache
  • Abdominal pain

More serious side effects are rare but can occur. Always inform your doctor if you experience any unusual symptoms while taking Cetrorelix.

Questions people often ask

Conditions where Cetrorelix is being studied

Each condition opens its own overview and trial list

Trials with Cetrorelix

Recruiting trials first

See all 2 →
Quick filters
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.